Korean J Intern Med.
2013 May;28(3):386-386. 10.3904/kjim.2013.28.3.386.
Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
- Affiliations
-
- 1Department of Biochemistry, Namik Kemal University Faculty of Medicine, Tekirdag, Turkey.
- 2Department of Biochemistry, Taksim Education and Research Hospital, Istanbul, Turkey.
- 3Department of Family Physician, Namik Kemal University Faculty of Medicine, Tekirdag, Turkey.
- 4Department of Internal Medicine, Taksim Training and Research Hospital, Istanbul, Turkey.
- 5Department of Biochemistry, Diyarbakir State Hospital, Diyarbakir, Turkey.
- 6Department of Biochemistry, Istanbul Education and Research Hospital, Istanbul, Turkey.
- KMID: 1776468
- DOI: http://doi.org/10.3904/kjim.2013.28.3.386
Abstract
- In the article, there were two spelling errors in the title and author affiliation.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Novel inflammatory biomarkers in acute coronary syndrome
- Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
- The effect of periodontal flap surgery on Matrix metalloproteinases (MMPs) and Tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) levels in gingival crevicular fluids of periodontitis patients
- Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 levels in Exudative Pleural Effusions
- EGCC inhibits tumor growth by inbibiting Matrix Metalloproteinase-9 induction in UM-SCC-1 cells
